INNOVADERM CRO IS NOW INDERO.

Episode 42: Ana Palijan – Basket Trials Require a High Level of Operational Expertise Upfront

Innovaderm to Indero

We sat down with Ana Palijan, Director of Early Phase and Translational Research at Indero. She’s a strategic clinical development leader and innovating disruptor with almost 20 years’ experience spanning early phase clinical development, translational research, and biomarker-driven programs across many therapeutic areas, currently dermatology, and author of more than 40 peer-reviewed publications.  Today, we’re talking about basket trials and clinical research, specifically in […]

Episode 40: Diane Leclerc – Leading from the Ground Up: Strategy, Transition, and Team Accountability

Innovaderm to Indero

This episode examines ways organizations can empower teams to influence strategy, drive key decisions, and take ownership of outcomes. Three main topics are addressed: ground-driven strategy through practical insights, the establishment of team accountability, and the management of leadership transitions. Practical strategies and real-world examples from clinical research, as shared by Diane Leclerc, Global Head […]

The Strategic Power of Public Relations in Scientific and Technical Industries

With 2 decades of experience in marketing across scientific, technical, and medical B2B sectors, Sarah Ballard, Agency Director at kdm communications, brings insight into the role of public relations (PR). Known for her strategic mindset and empathetic leadership, Sarah has helped numerous organizations navigate the complexities of integrated communications and build impactful PR campaigns. In […]

Episode 38: Raelle Kennedy (Woke Within Skin) – Eczema, Equity, and Empowerment

Innovaderm to Indero

  Our guest is Raelle Kennedy Brown, a brand marketing consultant, video producer, writer, patient advocate, and founder of Woke Within Skin, a platform dedicated to empowering individuals living with chronic conditions through storytelling, education, and community connection. Through Woke Within, Raelle blends advocacy, lived experience, and communication strategy to help organizations better understand the […]

Rethinking CRA Oversight

With more than 25 years of experience in clinical research, Isabel Dorion, Senior Director of Clinical Operations at Indero, has played a pivotal role in advancing trials from phase I through IV. Her deep understanding of both site-level operations and the complexities of the CRO landscape positions her as a leader in driving operational excellence. […]

Communication is Key to Unlocking Clinical Trial Success

The importance of clear, consistent communication between contract research organisations (CRO), sponsors and trial sites cannot be stressed enough. Effective collaboration between all contributors to a clinical trial is vital to ensure that differing needs and priorities are accommodated, from designing a project plan and setting milestones to establishing escalation pathways and driving timelines. Laura […]

Key Advantages of APAC for Sponsors

The Asia-Pacific (APAC) region is increasingly recognized as a strategic hub for global clinical research. With its vast and diverse patient populations, a blend of cost structures, and expanding government support, APAC offers unique advantages for sponsors seeking speed, scale, and efficiency. For clinical operations teams, success in APAC depends on understanding how to align […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.